Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Takami

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Biochemistry and Nutrition|June 4, 2016
Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenibNaoki Yamamoto, Takahiro Yamasaki, Taro Takami, et al.
Internal Medicine (Tokyo, Japan)|December 7, 2020
Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh ClassificationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Cell and Tissue Research|October 12, 2011
TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusionTakuro Hisanaga, Shuji Terai, Takuya Iwamoto, et al.
Plos One|September 27, 2019
A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classificationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Journal of Gastroenterology|February 25, 2021
Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenismTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
BMC Cancer|September 2, 2016
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivoHirofumi Harima, Seiji Kaino, Taro Takami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 19, 2015
Enhanced survival of mice infused with bone marrow-derived as compared with adipose-derived mesenchymal stem cellsShogo Shiratsuki, Shuji Terai, Yasuhiko Murata, et al.
Journal of Gastroenterology|September 27, 2012
Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosisIssei Saeki, Shuji Terai, Koichi Fujisawa, et al.
Journal of Medical Case Reports|May 11, 2025
Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patientsYuta Kimura, Yukio Tokumitsu, Yoshitaro Shindo, et al.
Surgery|July 13, 2025
Development of frozen-thawed allogeneic fibroblast sheets for esophageal anastomotic leakageRyunosuke Sakamoto, Koji Ueno, Yoshihiro Takemoto, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Biochemistry and Nutrition|June 4, 2016
Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenibNaoki Yamamoto, Takahiro Yamasaki, Taro Takami, et al.
Internal Medicine (Tokyo, Japan)|December 7, 2020
Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh ClassificationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Cell and Tissue Research|October 12, 2011
TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusionTakuro Hisanaga, Shuji Terai, Takuya Iwamoto, et al.
Plos One|September 27, 2019
A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classificationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Journal of Gastroenterology|February 25, 2021
Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenismTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
BMC Cancer|September 2, 2016
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivoHirofumi Harima, Seiji Kaino, Taro Takami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 19, 2015
Enhanced survival of mice infused with bone marrow-derived as compared with adipose-derived mesenchymal stem cellsShogo Shiratsuki, Shuji Terai, Yasuhiko Murata, et al.
Journal of Gastroenterology|September 27, 2012
Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosisIssei Saeki, Shuji Terai, Koichi Fujisawa, et al.
Journal of Medical Case Reports|May 11, 2025
Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patientsYuta Kimura, Yukio Tokumitsu, Yoshitaro Shindo, et al.
Surgery|July 13, 2025
Development of frozen-thawed allogeneic fibroblast sheets for esophageal anastomotic leakageRyunosuke Sakamoto, Koji Ueno, Yoshihiro Takemoto, et al.
Pageof 18